Shirley I. Miekka - Gaithersburg MD William N. Drohan - Springfield VA Thomas R. Jameson - Gaithersburg MD Manish P. Singh - San Diego CA Martin J. MacPhee - Montgomery Village MD
Assignee:
The American National Red Cross - Falls Church VA The Coalition for Hemophilia B - New York NY
The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.
Methods Of Production And Use Of Liquid Formulations Of Plasma Proteins
Shirley I. Miekka - Gaithersburg MD William N. Drohan - Springfield VA Thomas R. Jameson - Gaithersburg MD John R. Taylor - New York NY Manish S. Singh - Gaithersburg MD
Assignee:
The American National Red Cross - Falls Church VA Coalition for Hemophilia B, Inc. - New York NY
International Classification:
A61K 3514
US Classification:
530380
Abstract:
The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.
Methods Of Production And Use Of Liquid Formulations Of Plasma Proteins
Shirley I. Miekka - Gaithersburg MD William N. Drohan - Springfield VA Thomas R. Jameson - Gaithersburg MD Manish P. Singh - Gaithersburg MD John R. Taylor - New York NY Martin J. MacPhee - Montgomery Village MD
Assignee:
The American National Red Cross - Washington DC The Coalition for Hemophilia B - New York NY
International Classification:
A61K 3514
US Classification:
530380
Abstract:
The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.